Organon & Co. Dividend
A dividend is the cash a company pays its shareholders for each share they own, and the dividend yield is that payment as a percentage of the share price. Each row pairs a dividend per share with the split-adjusted closing price on its ex-dividend date, the first day a new purchaser is no longer entitled to that payment; the yield divides the dividend by that same-day close, never today's price. A higher yield means more cash paid per dollar of share price for that single payment. The annual view adds up the payments in each year and shows the latest yield.
- Organon & Co. dividend per share for the quarter ending 2026-08-14 was $0.02, a 0.00% change year-over-year.
- Organon & Co. dividend per share for the quarter ending 2026-05-11 was $0.02, a 0.00% change year-over-year.
- Organon & Co. dividend per share for the quarter ending 2026-02-23 was $0.02, a 92.86% decline year-over-year.
- Organon & Co. dividend per share for the quarter ending 2025-11-20 was $0.02, a 92.86% decline year-over-year.
- Available history
- 2021 to 2026-08-14
- Data captured
Historical Dividend
Annual Dividend
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |